Global Strategy: Carnage Continuation Amid Turkey Turmoil and US Dollar Breakout
Corrections across global ex-US markets continue to limit attractive investment opportunities from both a price and relative strength perspective. ...
481 Views
IPCA: Annual Report FY18: Normal Service to Resume
Ipca Laboratories (IPCA IN)'s FY18 revenue grew ~2.5% YoY to Rs. 32,587 mn. EBITDA stood at Rs. 4,812 mn (6.3% YoY growth), with the margins of...
455 Views
Global Strategy: Health Care Outperforming - Overweight; India Breaking Out -Add Exposure
Today's report puts a spotlight on the Health Care Sector, which is assuming a global leadership role vs. other Sectors. We also focus on...
518 Views
IPCA 4QFY18 Results Confirm Recovery Story
Performance Highlights IPCA Labs reported 4QFY18 revenue at Rs. 7,828 mn as against our expectation of Rs 7,666 mn. EBITDA stood at Rs. 1,099 mn,...
81 Views
IPCA Labs- The Revival Story
Ipca Laboratories Ltd (IPCA IN) is a fully integrated Indian pharmaceutical company. In FY17 45% of its revenues came from Indian dosage business,...
182 Views